Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-19-000183

Chief Financial Officer sold 5,000 shares at $6.00 ($30,000)

  • Chief Financial Officer gave up 10,102 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

File Justin J. · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-20 Shares withheld for taxes : show line 1 in the form −10,102 $5.74 $57,985 207,353 D
2019-11-20 Sale : show line 2 in the form −100 $6.00 $600 207,253 D
2019-11-21 Sale : show line 3 in the form −4,900 $6.00 $29,400 202,353 D
Open-market sales · 5,000 sh · avg $6.00 · $30,000
Loading xslF345X03/wf-form4_157438547271990.xml…